2008年至2012年墨西哥与艾滋病相关的早期死亡率
[AIDS-related early mortality in Mexico between 2008 and 2012].
作者信息
Silverman-Retana Omar, Bautista-Arredondo Sergio, Serván-Mori Edson, Lozano Rafael
机构信息
Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Institute for Health Metrics and Evaluation, UW, Estados Unidos.
出版信息
Salud Publica Mex. 2015;57 Suppl 2:s119-26.
OBJECTIVE
To describe the distribution of AIDS-related mortality according to the time of occurrence since entry to the System for the Administration, Logistics and Surveillance of Antiretrovirals (SALVAR, in Spanish), among users of Ministry of Health facilities in Mexico.
MATERIALS AND METHODS
Descriptive analysis of AIDS mortality and the related clinical and demographic profile of 41847 patients registered in SALVAR.
RESULTS
3195 patients (8.1%) died within the study period, 59% of these deaths occurred within six months after treatment initiation. Among those patients, 87.3% were diagnosed late, given their CD4 levels (CD4cel<200 cel/ml³).
CONCLUSION
Our results underscore the need to strengthen programs aimed to increase opportune HIV diagnosis and linkage to care, as a key component of universal access policy to antiretroviral treatment in Mexico.
目的
描述自进入抗逆转录病毒药物管理、后勤和监测系统（西班牙语缩写为SALVAR）以来，墨西哥卫生部设施使用者中艾滋病相关死亡率的发生时间分布情况。
材料与方法
对SALVAR登记的41847例患者的艾滋病死亡率及相关临床和人口统计学特征进行描述性分析。
结果
在研究期间，3195例患者（8.1%）死亡，其中59%的死亡发生在开始治疗后的6个月内。在这些患者中，87.3%因CD4水平（CD4细胞<200细胞/立方毫米）而诊断较晚。
结论
我们的结果强调需要加强旨在增加及时的艾滋病毒诊断和与护理联系的项目，这是墨西哥抗逆转录病毒治疗普及政策的关键组成部分。
Zotero 插件